Results Imminent From Sweden’s Pilot Of Novel Antibiotic Reimbursement Model
Executive Summary
If successful, a new Swedish model for reimbursing antibiotics that involves guaranteed minimum annual revenues for companies could be tested on other kinds of products.
You may also be interested in...
EU Countries Slam Transferable Exclusivity Voucher Proposal
A group of EU member states has written to the European Commission saying that an exclusivity voucher scheme intended to stimulate R&D into new antimicrobials will stifle innovation by competitor companies and push up costs for national health systems.
England: Shionogi And Pfizer Ink ‘World First’ Payment Model Deal For Antibiotics
Shionogi and Pfizer have formally agreed to a scheme that offers companies a new and sustainable payment model for innovating in antibiotics.
EU Falsified Medicines Directive ‘Not Working’ In Northern Ireland
Industry representatives told a House of Lords committee about continuing Brexit-related problems such as the extra work involved in checking compliance with the EU Falsified Medicines Directive and the drawbacks of a proposed “dual regulatory regime.”